期刊文献+

FMC化疗方案联合益气健脾活血汤治疗中晚期胃癌临床观察 被引量:8

Clinical Observation on FMC Chemotherapy Regimen Combined with YiqiJianpiHuoxue Tang for Advanced Gastric Cancer
下载PDF
导出
摘要 目的:观察FMC化疗方案联合益气健脾活血汤治疗中晚期胃癌的临床效果及其安全性。方法:将符合纳入标准的96例中晚期胃癌患者按随机数字表法分为2组各48例。对照组患者接受FMC化疗方案治疗,观察组在对照组治疗方案的基础上联合益气健脾活血汤治疗,对2组患者治疗后效果及毒副作用发生情况进行观察。结果:观察组治疗后有效率43.75%,对照组22.92%,2组比较,差异有统计学意义(P<0.05);观察组治疗后毒副反应发生率均低于对照组,差异有统计学意义(P<0.05)。结论:中晚期胃癌接受FMC化疗方案联合益气健脾活血汤治疗效果满意,不仅能提高肿瘤控制效果,也能缓解症状,降低毒副反应发生率,提高患者生存质量,利于远期预后。 Objective: To observe the clinical effect and safety of the therapy of FMC chemotherapy regimen combined with Yiqi Jianpi Huoxue tang in treating advanced gastric cancer. Methods: Divided 96 cases of patients with advanced gastric cancer according with standard into two groups randomly,48 cases in each group. The two groups were both treated with FMC chemotherapy regimen,but the observation group additionally received Yiqi Jianpi Huoxue tang for treatment. Observed the curative effect and toxic side effects in both groups after treatment. Results:The total effective rate after treatment was 43.75% in the observation group and22.92% in the control group, the significant difference being found in the comparison between two groups(P〈0.05). The incidence of toxic side effect of the observation group after treatment was lower than that of the control group,the difference being significant(P〈0.05). Conclusion: The effect of patients with advanced gastric cancer receiving FMC chemotherapy regimen combined with Yiqi Jianpi Huoxue tang is satisfying. This therapy can not only enhance the effect of tumor control, but also relieve symptoms, reduce the incidence of toxic side effect and elevate patients’ life quality, which is beneficial to long-term prognosis.
出处 《新中医》 CAS 2017年第2期124-126,共3页 New Chinese Medicine
关键词 中晚期胃癌 中西医结合疗法 益气健脾活血汤 化学疗法 FMC化疗方案 临床疗效 毒副反应 Advanced gastric cancer Integrated Chinese and western medicine therapy Yiqi Jianpi Huoxue tang Chemotherapy regimen FMC Chemotherapy regimen Clinical effect Toxic side effect
  • 相关文献

参考文献9

二级参考文献73

  • 1王刚,董玫,郭会灿,赵松.中药半枝莲提取物体外抗肿瘤活性研究[J].河北中医,2006,28(9):701-702. 被引量:33
  • 2孟志强,刘鲁明,马鑫,林钧华,陈震,陈颢,周振华,王琨,于尔辛.394例原发性肝癌的预后因素与疗效分析[J].中国癌症杂志,2007,17(8):628-632. 被引量:18
  • 3蓝云.实用肿瘤内科学[M].北京:人民卫生出版社,1999:641.
  • 4Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [J] . J Natl Cancer Inst, 2000, 92 (3): 205-216.
  • 5Ajani JA.Evolving chemotherapy for advanced gastric cancer[J].Oncologist,2005,10(13):49-58.
  • 6雷载权 张廷模.中华临床中药学[M].北京:人民卫生出版社,1998.1009.
  • 7陈新谦 金有豫 汤光.新编药物学[M]15版[M].北京:人民卫生出版社,2003.583.
  • 8王晓娜,丁学伟,张李,张晖,刘宁,张汝鹏,梁寒.淋巴结外软组织阳性胃癌预后相关分析[J].中华胃肠外科杂志,2007,10(5):436-439. 被引量:16
  • 9张海,徐力.胃癌患者化疗前后中医证候特征研究[D].南京:南京中医药大学,2008.
  • 10徐力.论中医干预癌症转移前环境[J].中国中医药信息杂志,2007,14(10):3-4. 被引量:40

共引文献359

同被引文献142

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部